NEWS: "Hot Off the Press"
- Drone Beyond Visual Line of Sight (BVLOS)
- ZenaTech Announces the Acquisition of Tucson-based Putt Land Surveying Inc., and Acceleration of Drone as a Service (DaaS) Growth in the Phoenix Area and Across Arizona
- Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals, presents at Noble Capital Markets Virtual Emerging Growth Conference
- 10 Essential Drone Safety Tips
- How Drones Detect and Avoid Obstacles
- Alpha Modus Escalates Patent Enforcement Offensive Targeting Global Retail Tech Giants
- Precision Farming Drones: Tech, Benefits, Future
- Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
- Affluence Subsidiary Diprotech, Part of MTi Group, Selected by Navantia to Equip Crane Systems with IoT Sensors in New Digitalization Contract
- Alpha Modus (NASDAQ: AMOD) Ranked #10 on Insider Monkey’s Oversold Tech Stocks to Watch
- From Centralized Control to Sovereign Systems: Rethinking Energy, Intelligence and Infrastructure for the IoT, AI Revolution
- Alpha Modus Launches Patent Infringement Suit Against RetailNext – Targeting Use of AI Technologies in Global Retail Analytics
- Affluence Corporation Subsidiary MTi and Aerodyne Group Form Strategic Partnership
- Alpha Modus Expands Patent Arsenal as USPTO Grants New Patent, Protecting AI Retail Systems Tracking Products and Customer Behavior at Point of Sale
- Alpha Modus Presenting at The H.C. Wainwright 27th Annual Global Investment Conference
- Information Security Strategies That Actually Work Because They’re Built for Change
- Affluence Corporation Issues Shareholder Letter Highlighting Post-Merger Financial Performance, Restructuring Progress, and Uplisting Strategy
- Affluence Corporation Strengthens Acquisition Strategy to Drive Scalable Growth
- What Are Managed IT Services?
- AI Chatbots: A Transformative Market Set to Soar Beyond 2026
- Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
- Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by New to The Street TV.
